Arbutus Biopharma (ABUS) Return on Assets: 2010-2025
Historic Return on Assets for Arbutus Biopharma (ABUS) over the last 15 years, with Sep 2025 value amounting to -0.42%.
- Arbutus Biopharma's Return on Assets rose 9.00% to -0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.42%, marking a year-over-year increase of 9.00%. This contributed to the annual value of -0.51% for FY2024, which is 8.00% down from last year.
- According to the latest figures from Q3 2025, Arbutus Biopharma's Return on Assets is -0.42%, which was up 14.63% from -0.49% recorded in Q2 2025.
- In the past 5 years, Arbutus Biopharma's Return on Assets registered a high of -0.31% during Q2 2022, and its lowest value of -0.62% during Q1 2025.
- Moreover, its 3-year median value for Return on Assets was -0.49% (2025), whereas its average is -0.48%.
- In the last 5 years, Arbutus Biopharma's Return on Assets soared by 92bps in 2021 and then declined by 14bps in 2024.
- Arbutus Biopharma's Return on Assets (Quarterly) stood at -0.41% in 2021, then increased by 6bps to -0.35% in 2022, then fell by 13bps to -0.48% in 2023, then decreased by 3bps to -0.51% in 2024, then rose by 9bps to -0.42% in 2025.
- Its Return on Assets was -0.42% in Q3 2025, compared to -0.49% in Q2 2025 and -0.62% in Q1 2025.